CD274 and neoplasm: When ICP inhibitors, such as antibodies against PD-L1 and PD-1, “release the brakes” and are allowed to react to a specified antigen, PD-1 is unable to transmit PD-L1 signals, and an anti-tumor effect is exerted [5].